Lactosolv
Natural health product licensed in Canada
- Licence holder
- Sciotec Diagnostic Technologies GmbH
- NPN or DIN-HM
- 80038223
- Status
- Active licence
- Licence date
- 12 December 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-D-galactoside galactohydrolase Source : Kluyveromyces marxianus var. lactis - Whole | 4,600 FCC NLU | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Kluyveromyces marxianus var. lactis - Whole | 9.85 mg | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Lactase | 4,600 FCC NLU | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Lactase | 9.85 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Gomme-laque, Carboxyméthylcellulose, Dioxyde de titane, Amidon, Acétate, Oxydé, Hydroxypropylcellulose, Polyvinylpyrrolidone, Chlorure de magnésium, Cellulose microcristalline, Glycérol, Talc, Carbonate de sodium, Maltose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Digestive enzyme/lactase to assist in the digestion of foods containing lactose. Helps prevent symptoms of lactose intolerance (including gas, bloating, cramping and diarrhea).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes or galactosemia. Discontinue use and consult a health care practitioner if symptoms persist or worsen.
- Effets indésirables connus
Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80038223
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.